Natixis Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $316K | Buy |
13,207
+68
| +0.5% | +$1.63K | ﹤0.01% | 1541 |
|
|
2025
Q1 | $327K | Buy |
+13,139
| New | +$327K | ﹤0.01% | 1534 |
|
|
2024
Q3 | – | Sell |
-11,413
| Closed | -$327K | – | 1632 |
|
|
2024
Q2 | $327K | Sell |
11,413
-404
| -3% | -$11.6K | ﹤0.01% | 1509 |
|
|
2024
Q1 | $345K | Buy |
+11,817
| New | +$345K | ﹤0.01% | 1454 |
|
|
2023
Q3 | – | Sell |
-11,993
| Closed | -$481K | – | 1518 |
|
|
2023
Q2 | $481K | Buy |
11,993
+1,638
| +16% | +$65.7K | ﹤0.01% | 1344 |
|
|
2023
Q1 | $423K | Buy |
+10,355
| New | +$423K | ﹤0.01% | 1354 |
|
|
2022
Q4 | – | Sell |
-12,515
| Closed | -$666K | – | 1498 |
|
|
2022
Q3 | $666K | Buy |
+12,515
| New | +$666K | ﹤0.01% | 1211 |
|
|
2022
Q2 | – | Sell |
-12,898
| Closed | -$984K | – | 1494 |
|
|
2022
Q1 | $984K | Buy |
12,898
+2,381
| +23% | +$182K | ﹤0.01% | 1137 |
|
|
2021
Q4 | $633K | Buy |
+10,517
| New | +$633K | ﹤0.01% | 1203 |
|
|
2020
Q4 | – | Sell |
-38,528
| Closed | -$2.32M | – | 1237 |
|
|
2020
Q3 | $2.32M | Buy |
38,528
+1,894
| +5% | +$114K | 0.01% | 752 |
|
|
2020
Q2 | $1.92M | Buy |
36,634
+15,228
| +71% | +$799K | 0.01% | 813 |
|
|
2020
Q1 | $718K | Buy |
+21,406
| New | +$718K | 0.01% | 980 |
|